CMS grants 11 more Medicaid waivers to states dealing with coronavirus

Eleven more states are following the lead of Florida and Washington in applying for Section 1135 Medicaid waivers to be granted more flexibility in dealing with the spread of the new coronavirus, COVID-19. The waivers open up more options to quickly respond to the pandemic, such as removing prior authorization barriers.

CMS recently announced it was expanding telehealth benefits for providers to better diagnose and treat patients who potentially have COVID-19. The agency also recently announced states could apply for further flexibilities. The waivers are effective March 1 through the termination of the public health emergency period, which was declared by President Trump March 13.

“CMS has been able to swiftly remove barriers and cut red tape for our state partners,” CMS Administrator Seema Verma said in a statement. “These waivers give a broad range of states the regulatory relief and support they need to more quickly and effectively care for their most vulnerable citizens.”

The total number of states taking advantage of the waivers is 13, as of March 24.

The states with the newly approved Medicaid waivers include:

  • Alabama
  • Arizona
  • California
  • Illinois
  • Louisiana
  • Mississippi
  • New Hampshire
  • New Jersey
  • New Mexico
  • North Carolina
  • Virginia

The waivers available under Section 1135 include a variety of options for states under a national emergency, including: temporarily suspending prior authorization requirements; extending existing authorizations for services through the public health emergency; modifying timelines for state hearing and appeals; relaxing provider enrollment requirements; and relaxing public notice and submission deadlines for certain Medicaid state plan amendments focused on COVID-19, according to CMS.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup